首页|α-硫辛酸联合前列地尔治疗对糖尿病足患者微血管生成、氧化应激及创面愈合的影响

α-硫辛酸联合前列地尔治疗对糖尿病足患者微血管生成、氧化应激及创面愈合的影响

扫码查看
目的 探究α-硫辛酸联合前列地尔治疗对糖尿病足(DF)患者微血管生成、氧化应激及创面愈合的影响.方法 采用随机数字表法将 98 例DF患者分为联合组(49 例)和对照组(49 例).对照组接受前列地尔治疗,联合组接受α-硫辛酸联合前列地尔治疗.比较两组患者临床疗效、创面微血管生成情况、氧化应激反应及创面愈合情况.结果 联合组临床总有效率 95.91%显著高于对照组的 81.63%(P<0.05).治疗 1 个月后,两组血管内皮生长因子(VEGF)水平显著高于治疗前、内皮抑素(ES)水平显著低于治疗前,联合组VEGF(135.28±13.58)ng/L显著高于对照组的(103.29±12.39)ng/L、ES(41.06±4.59)ng/ml显著低于对照组的(49.68±5.12)ng/ml(P<0.05).治疗 1 个月后,两组超氧化物歧化酶(SOD)水平显著高于治疗前、丙二醛(MDA)水平显著低于治疗前,联合组SOD(92.77±10.25)U/ml显著高于对照组的(86.29±9.21)U/ml、MDA(2.29±0.94)μmol/L显著低于对照组的(2.97±1.06)μmol/L(P<0.05).联合组创面愈合时间(16.28±3.12)d显著短于对照组的(21.58±4.05)d,创面愈合率(76.29±10.39)%显著高于对照组的(54.95±11.28)%(P<0.05);治疗 1 个月后,两组创周肿势评分均低于本组治疗前,联合组创周肿势评分(0.93±0.34)分显著低于对照组的(1.17±0.41)分(P<0.05).结论 α-硫辛酸联合前列地尔治疗DF患者较前列地尔单药治疗的临床效果更显著,促进微血管生成,改善氧化应激反应,促进创面愈合.
Effect of combined treatment with α-lipoic acid and alprostadil on micro-angiogenesis,oxidative stress and wound healing in patients with diabetic foot
Objective To explore the effect of combined treatment with α-lipoic acid and alprostadil on micro-angiogenesis,oxidative stress and wound healing in patients with diabetic foot(DF).Methods Using the random number table method,98 patients with DF were divided into the combination group(49 cases)and the control group(49 cases).The control group was treated with alprostadil,while the combination group was treated with α-lipoic acid combined with alprostadil.The clinical efficacy,micro-angiogenesis,oxidative stress response,and wound healing were compared between the two groups.Results The total clinical effective rate of 95.91%in the combination group was significantly higher than 81.63%in the control group(P<0.05).After 1 month of treatment,the level of vascular growth endothelial factor(VEGF)in both groups was significantly higher than that before treatment,and the level of endostatin(ES)was significantly lower than that before treatment;the combination group had significantly higher VEGF of(135.28±13.58)ng/L than(103.29±12.39)ng/L in the control group,and significantly lower ES of(41.06±4.59)ng/ml than(49.68±5.12)ng/ml in the control group(P<0.05).After 1 month of treatment,the level of superoxide dismutase(SOD)in both groups was significantly higher than that before treatment,and the level of malondialdehyde(MDA)was significantly lower than that before treatment;SOD of(92.77±10.25)U/ml in the combination group was significantly higher than(86.29±9.21)U/ml in the control group;MDA of(2.29±0.94)μmol/L in the combination group was significantly lower than(2.97±1.06)μmol/L in the control group(P<0.05).The wound healing time of(16.28±3.12)d in the combination group was significantly shorter than(21.58±4.05)d in the control group,and the wound healing rate of(76.29±10.39)%was significantly higher than(54.95±11.28)%in the control group(P<0.05).After 1 month of treatment,the wound swelling score in both groups were lower than that before treatment,and the wound swelling score of(0.93±0.34)points in the combination group was significantly lower than(1.17±0.41)points in the control group(P<0.05).Conclusion Compared to monotherapy with alprostadil,the combined treatment with α-lipoic acid and alprostadil is more effective in treating patients with DF.The latter can promote micro-angiogenesis,improve oxidative stress response,and promote wound healing.

Diabetic footAlprostadilα-lipoic acidWound healing

高华敏、陈霞明

展开 >

200135 上海瑞东医院药剂科

237200 安徽省霍山县医院药品管理科

糖尿病足 前列地尔 α-硫辛酸 创面愈合

2024

中国实用医药
中国康复医学会

中国实用医药

影响因子:0.797
ISSN:1673-7555
年,卷(期):2024.19(10)
  • 10